# CIAPIN1

## Overview
CIAPIN1, or cytokine-induced apoptosis inhibitor 1, is a gene that encodes a protein involved in the regulation of apoptosis and various cellular processes, including cell survival, proliferation, and differentiation. The CIAPIN1 protein is characterized by its ability to bind iron-sulfur clusters, which are crucial for its function in cytosolic iron-sulfur protein biogenesis (CiofiBaffoni2018Protein). It is ubiquitously expressed in both fetal and adult tissues, with a notable presence in differentiated cells and tissues with high metabolic activity (Hao2006Distribution). The protein is primarily localized in the cytoplasm and nucleus, with significant accumulation in the nucleoli, suggesting a role in ribosome subunit biogenesis (Hao2008Successful). CIAPIN1 is also implicated in the Ras signaling pathway and has been associated with multidrug resistance in cancer cells, making it a potential target for therapeutic interventions (Li2007A).

## Structure
The CIAPIN1 protein, encoded by the human gene CIAPIN1, features a CIAPIN1 domain characterized by two highly conserved, cysteine-rich motifs: CX8CX2CXC and CX2CX7CX2C. These motifs are essential for binding iron-sulfur clusters, specifically a [2Fe-2S] cluster in the first motif and either a [2Fe-2S] or a [4Fe-4S] cluster in the second motif, depending on conditions (CiofiBaffoni2018Protein). The CIAPIN1 domain is largely unstructured and is connected to a well-structured N-terminal domain by a flexible linker of 51 residues. The N-terminal domain resembles a typical S-adenosylmethionine (SAM) dependent methyltransferase fold but lacks the glycine-rich motif necessary for SAM binding, indicating it does not have SAM-dependent methyltransferase activity (CiofiBaffoni2018Protein). 

The protein is expressed in both fetal and adult human tissues, with higher expression in differentiated cells and tissues with active metabolism. It is localized to the cytoplasm and nucleus, accumulating in the nucleoli (Hao2008Successful). Despite predictions of a methyltransferase motif, experimental tests did not confirm any DNA or RNA methyltransferase activity, DNA demethylase activity, or AdoMet binding capability for CIAPIN1 (Hao2008Successful).

## Function
CIAPIN1, also known as cytokine-induced apoptosis inhibitor 1, is a protein that plays a significant role in inhibiting apoptosis and is involved in various cellular processes, including cell survival, proliferation, and differentiation. It is ubiquitously expressed in both fetal and adult human tissues, indicating its fundamental role in cellular function (Hao2006Distribution; Hao2006Subcellular).

CIAPIN1 is localized in the cytoplasm, nucleus, and nucleolus, suggesting its involvement in nucleocytoplasmic shuttling. This localization pattern is supported by the presence of a nuclear localization signal (NLS) and a nuclear export signal (NES), which facilitate its movement between cellular compartments (Hao2006Subcellular). The protein's accumulation in the nucleolus hints at a potential role in ribosome subunit biogenesis, as the nucleolus is primarily involved in the transcription and assembly of rRNA into ribosome subunits (Hao2006Subcellular).

CIAPIN1 is associated with the Ras signaling pathway, which regulates cell growth and differentiation. Its expression is upregulated in differentiated tissues, suggesting a role in promoting cell differentiation (Hao2006Distribution). The protein is also implicated in mediating multidrug resistance in cancer cells by regulating the expression of genes such as mdr-1, bcl-2, and bax, which are involved in apoptosis and drug resistance pathways (Li2007A).

## Clinical Significance
Alterations in the expression of the CIAPIN1 gene have been implicated in various cancers, affecting tumor progression and response to treatment. In gastric cancer, CIAPIN1 is downregulated, which may contribute to carcinogenesis by promoting cell proliferation and cell cycle progression. This downregulation is associated with a stepwise decrease from normal gastric mucosa to adenocarcinoma, suggesting its role as a tumor suppressor (Li2007CIAPIN1; Hao2009Downregulated). In contrast, CIAPIN1 is overexpressed in hepatocellular carcinoma (HCC) and gastric cancer tissues, where it acts as a suppressor of cell proliferation by inducing cell cycle arrest at the G1/S phase (Li2010CIAPIN1).

CIAPIN1 is also involved in multidrug resistance (MDR) in leukemia and breast cancer cells. In leukemia, CIAPIN1 overexpression is linked to increased resistance to various chemotherapeutic drugs by upregulating MDR-1 and Bcl-2 expression while downregulating Bax, contributing to the MDR phenotype (Li2007A). Similarly, in breast cancer, CIAPIN1 influences MDR by regulating MDR1 mRNA and P-glycoprotein levels, affecting drug sensitivity and apoptosis (Lu2012Down). These findings highlight CIAPIN1's potential as a therapeutic target in cancer treatment.

## Interactions
CIAPIN1, also known as cytokine-induced apoptosis inhibitor 1, is involved in various protein interactions that influence its function in cellular processes. It interacts with the mitochondrial oxidoreductase Mia40, forming disulfide bonds crucial for its import and retention in the mitochondrial intermembrane space (IMS). This interaction is essential for CIAPIN1's role in cytosolic iron-sulfur (Fe/S) protein biogenesis (Banci2011Anamorsin).

CIAPIN1 also interacts with the yeast protein Tah18, forming a complex that is significant in oxidative stress response. This interaction is conserved in humans, where CIAPIN1 can replace the yeast protein Dre2, indicating a shared function in maintaining mitochondrial integrity and controlling cell death (Vernis2009A).

In the context of cancer, CIAPIN1 interacts with proteins involved in apoptosis regulation, such as Bcl-2 and Bax, influencing multidrug resistance in leukemia cells. It upregulates Bcl-2 and MDR-1 expression while downregulating Bax, contributing to its role in chemotherapy resistance (Li2007A).

CIAPIN1's interactions extend to the JAK2-STAT3 signaling pathway, where it enhances JAK2 expression and activation, affecting cell proliferation and survival (Han2021Cytokine‐induced).


## References


[1. (CiofiBaffoni2018Protein) Simone Ciofi-Baffoni, Veronica Nasta, and Lucia Banci. Protein networks in the maturation of human iron–sulfur proteins. Metallomics, 10(1):49–72, 2018. URL: http://dx.doi.org/10.1039/c7mt00269f, doi:10.1039/c7mt00269f. This article has 83 citations and is from a peer-reviewed journal.](https://doi.org/10.1039/c7mt00269f)

[2. (Hao2009Downregulated) Zhiming Hao, Xiaohua Li, Taidong Qiao, Shuang Li, Yifei Lv, and Daiming Fan. Downregulated expression of ciapin1 may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression. Cancer Biology &amp; Therapy, 8(11):1064–1070, June 2009. URL: http://dx.doi.org/10.4161/cbt.8.11.8796, doi:10.4161/cbt.8.11.8796. This article has 14 citations.](https://doi.org/10.4161/cbt.8.11.8796)

[3. (Hao2008Successful) Zhiming Hao, Xiaohua Li, Taidong Qiao, and Daiming Fan. Successful expression and purification of human ciapin1 in baculovirus-insect cell system and application of this system to investigation of its potential methyltransferase activity. International Journal of Biological Macromolecules, 42(1):27–32, January 2008. URL: http://dx.doi.org/10.1016/j.ijbiomac.2007.08.009, doi:10.1016/j.ijbiomac.2007.08.009. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ijbiomac.2007.08.009)

[4. (Li2007A) Xiaohua Li, Liu Hong, Yunping Zhao, Haifeng Jin, Rui Fan, Rui Du, Lin Xia, Guanhong Luo, and Daiming Fan. A new apoptosis inhibitor, ciapin1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating mdr-1, bcl-2, and bax. Biochemistry and Cell Biology, 85(6):741–750, December 2007. URL: http://dx.doi.org/10.1139/O07-141, doi:10.1139/o07-141. This article has 44 citations.](https://doi.org/10.1139/O07-141)

[5. (Li2010CIAPIN1) Xiaohua Li, Kaichun Wu, and Daiming Fan. Ciapin1 as a therapeutic target in cancer. Expert Opinion on Therapeutic Targets, 14(6):603–610, April 2010. URL: http://dx.doi.org/10.1517/14728221003774127, doi:10.1517/14728221003774127. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1517/14728221003774127)

[6. (Banci2011Anamorsin) Lucia Banci, Ivano Bertini, Simone Ciofi-Baffoni, Francesca Boscaro, Afroditi Chatzi, Maciej Mikolajczyk, Kostas Tokatlidis, and Julia Winkelmann. Anamorsin is a [2fe-2s] cluster-containing substrate of the mia40-dependent mitochondrial protein trapping machinery. Chemistry &amp; Biology, 18(6):794–804, June 2011. URL: http://dx.doi.org/10.1016/j.chembiol.2011.03.015, doi:10.1016/j.chembiol.2011.03.015. This article has 65 citations.](https://doi.org/10.1016/j.chembiol.2011.03.015)

[7. (Vernis2009A) Laurence Vernis, Céline Facca, Emmanuelle Delagoutte, Nicolas Soler, Roland Chanet, Bernard Guiard, Gérard Faye, and Giuseppe Baldacci. A newly identified essential complex, dre2-tah18, controls mitochondria integrity and cell death after oxidative stress in yeast. PLoS ONE, 4(2):e4376, February 2009. URL: http://dx.doi.org/10.1371/journal.pone.0004376, doi:10.1371/journal.pone.0004376. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0004376)

[8. (Han2021Cytokine‐induced) Joo‐Hui Han, Kyung‐Sun Heo, and Chang‐Seon Myung. Cytokine‐induced apoptosis inhibitor 1 (ciapin1) accelerates vascular remodelling via p53 and jak2‐stat3 regulation in vascular smooth muscle cells. British Journal of Pharmacology, 178(22):4533–4551, August 2021. URL: http://dx.doi.org/10.1111/bph.15631, doi:10.1111/bph.15631. This article has 14 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1111/bph.15631)

[9. (Hao2006Distribution) Zhiming Hao, Xiaohua Li, Taidong Qiao, Jing Zhang, Xiaodong Shao, and Daiming Fan. Distribution of ciapin1 in normal fetal and adult human tissues. Journal of Histochemistry &amp; Cytochemistry, 54(4):417–426, April 2006. URL: http://dx.doi.org/10.1369/jhc.5a6753.2005, doi:10.1369/jhc.5a6753.2005. This article has 24 citations.](https://doi.org/10.1369/jhc.5a6753.2005)

[10. (Lu2012Down) Dan Lu, Zhibo Xiao, Wenxiu Wang, Yuqing Xu, Shujian Gao, Lili Deng, Wen He, Yu Yang, Xiaofei Guo, and Xuemei Wang. Down regulation of ciapin1 reverses multidrug resistance in human breast cancer cells by inhibiting mdr1. Molecules, 17(6):7595–7611, June 2012. URL: http://dx.doi.org/10.3390/molecules17067595, doi:10.3390/molecules17067595. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules17067595)

[11. (Li2007CIAPIN1) Xiaohua Li, Zhiming Hao, Rui Fan, Xue Zou, Haifeng Jin, Yanglin Pan, Lijie He, Rui Du, Lin Gao, Jie Liu, and Daiming Fan. Ciapin1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating cyclyind1 and upregulating p27. Cancer Biology &amp; Therapy, 6(10):1539–1545, October 2007. URL: http://dx.doi.org/10.4161/cbt.6.10.4684, doi:10.4161/cbt.6.10.4684. This article has 28 citations.](https://doi.org/10.4161/cbt.6.10.4684)

[12. (Hao2006Subcellular) Zhiming Hao, Xiaohua Li, Taidong Qiao, Rui Du, Guoyun Zhang, and Daiming Fan. Subcellular localization of ciapin1. Journal of Histochemistry &amp; Cytochemistry, 54(12):1437–1444, December 2006. URL: http://dx.doi.org/10.1369/jhc.6A6960.2006, doi:10.1369/jhc.6a6960.2006. This article has 41 citations.](https://doi.org/10.1369/jhc.6A6960.2006)